Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available. Fresenius, headquartered in Bad Homburg, Germany, offers products and services for dialysis, infusion and transfusion therapy and for the treatment of patients in the hospital and home environments. The company comprises three main business units: Fresenius Medical Care, Fresenius Kabi and Fresenius ProServe:-

Fresenius Medical Care is the world's largest manufacturer and distributor of products for haemodialysis and a major manufacturer of peritoneal dialysis products. It also claims to be the world's leading dialysis care provider.

Fresenius Kabi is focused on nutrition and infusion therapy and transfusion technology.

Fresenius ProServe is a healthcare services and management company. Fresenius ProServe will be replaced by two new segments in January 2008: Fresenius HELIOS and Fresenius VAMED.

In addition, Fresenius Biotech develops products and procedures for immune and cell therapies, while Fresenius Netcare is focused on IT services for the healthcare and pharmaceutical sectors.

Based on Fresenius' strong financial results for the third quarter, the company now expects its net income to increase by over 25% in constant currency for fiscal 2007 as a whole, while sales are expected to grow by 9 to 10% excluding exchange rates. Previously, the company expected net income to increase by around 25% and sales to grow by 8 to 10% in constant currency.

In the mid-term, Fresenius is targeting revenue of EUR 15 billion and an EBIT margin of 15% by the year 2010. The company plans to achieve this target through sales and earnings growth in all business segments. In addition, it will be looking to strengthen its business segments through small and mid-sized acquisitions. The company's key strategic aims are to achieve growth through international expansion, particularly in Asia, Latin America and Eastern Europe, the development of new products, the expansion of its services business and selective acquisitions.